课题基金 / 基金详情

Molecular basis of prostanoid receptor-mediated pathogenesis and its drug application

Molecular basis of prostanoid receptor-mediated pathogenesis and its drug application
前列腺素受体介导发病机制的分子基础及其药物应用
批准号:
12557211
负责人:
ICHIKAWA Atsushi
金额:
$8.51万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

ICHIKAWA Atsushi的其他基金

相似基金

相关文献

中文摘要
翻译
(1)通过每种受体缺乏小鼠阐明前列腺素的病理生理作用:我们发现EP2缺乏在apc KO小鼠中减少了肠息肉的形成数量和大小。我们还发现野生型小鼠肠息肉中COX-2、EP2和VEGF表达加快,而EP2和Ape双敲除小鼠肠息肉中COX-2和VEGF表达微弱,提示COX-2和EP2之间存在正反馈调节。我们将dextransulfate (DSS)诱导的结肠炎模型引入ep缺陷小鼠。结果,只有ep4缺陷小鼠在3%DSS处理后出现严重结肠炎,而野生型小鼠没有明显的结肠炎。EP4已被证明能促进上皮细胞再生并抑制白细胞和淋巴细胞的活化。(2)前列腺素受体EP3发挥的信号转导新途径:EP3已被证明与Gi活性偶联,抑制腺苷酸周期和更多lase。EP3有多种异构体,它们的c端结构和激动剂依赖性Gi活性不同。我们发现,在COS-7细胞中表达的EP3受体以激动剂依赖的方式增强了其他受体刺激的Gs活性。EP3受体对Gs的超激活不受百日咳毒素处理的影响,表明这种超激活不是由gi介导的。无论EP3受体的c端结构如何,在任何类型的小鼠EP3受体亚型中都观察到Gs依赖于EP3激动剂的超激活。这种EP3信号可能反映了PGE2生理功能的某些方面,如痛觉。(3) EP4受体特异性配体的开发:研究了通过在PGE1 α链中引入杂原子来提高EP4受体的选择性和激动剂活性。在所合成的化合物中,16-苯基-omega-四烷-3,7-二硫apge1具有中等的ep4受体选择性和激动剂活性,被确定为新的化学先导物,可以通过修饰芳香部分进行进一步优化。在此基础上,我们还成功地合成了具有高选择性的ep4特异性拮抗剂。少
英文摘要
Results obtained by Kyoto University Group(1) Elucidation of patho-physiological roles of prostanoids by using each receptor-deficient mice :We found that EP2 deficiency attenuated intestinal polyp formation both in number and size in-Apc KO mice. We also showed acceleration of COX-2, EP2 and VEGF expression in the intestinal polyps of wild-type mice, but faint expression of COX-2 or VEGF in those of EP2 and Ape double-knockout mice, suggesting that there exists positive feedback regulation between COX-2 and EP2. We introduced dextransulfate (DSS)-induced colitis model into EP-deficient mice. As a result, only EP4-deficient mice showed severe colitis upon 3%DSS treatment that did not induce significant colitisin wild-type mice. EP4 has been shown to promote epithelial regeneration and to inhibit activation of leukocytes and lymphocytes.(2) The new signal transduction pathway exerted by prostanoid receptor EP3 :EP3 has been shown to be coupled to Gi activity, inhibition of adenylate cyc … More lase. EP3 has multiple isoforms that are different in their C-terminal structure and in their agonist-dependent Gi activity. We found that EP3 receptors expressed in COS-7 cells showed augmentation of other receptor-stimulated Gs activity in an agonist-dependent manner. The superactivation of Gs by EP3 receptors was not affected by the treatment of pertussis toxin, suggesting that the superactivation is not Gi-mediated. The EP3 agonist-dependent supeactivation of Gs is observed in any type of mouse EP3 receptor isoforms, irrespective of C-termnal structure of EP3 receptor. This EP3 signaling may reflect some aspects of the physiological function of PGE2, such as pain sensation.]Results obtained by Ono Pharmaceutical Co. Group(3) Development of EP4 receptor-specific ligands :Improvement of EP4-receptor selectivity and the agonist activity by introduction of heteroatoms into the alpha chain of PGE1 was investigated. Of the compounds produced, 16-phenyl-omega-tetranor-3,7-dithiaPGE1 possessing moderate EP4-receptor selectivity and agonist activity, was identified as a new chemical lead for further optimization by modification of the aromatic moiety Based on the information, we also successfully generated an EP4-specific antagonist with a high selectivity. Less
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
Ma H, Hara A, Xiao CY, et al.: "Increased bleeding tendency and decreased susceptibility to thromboembolism in mice lacking the prostaglandin E receptor subtype EP3"Circulation. 104. 1176-1180 (2001)
Ma H、Hara A、Xiao CY 等人:“缺乏前列腺素 E 受体亚型 EP3 的小鼠出血倾向增加,血栓栓塞的易感性降低”循环。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hatae, N., et al.: "Augmentation of Receptor-Mediated Adenylyl Cyclase Activity by Gi-Coupled Prostaglandin Receptor Subtype EP3 in a Gβγ Subunit-Independent Manner"Biochem. Biophys. Res. Commun.. 290. 162-168 (2002)
Hatae,N.,等人:“Gi 偶联前列腺素受体亚型 EP3 以不依赖 Gβγ 亚基的方式增强受体介导的腺苷酸环化酶活性”Biochem. 290. 162-168 (2002) )
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hatae, N., Yamaoka, K., Sugimoto, et al.: "Augmentation of Receptor-Mediated Adenylyl Cyclase Activity by Gi-Coupled Prostaglandin Receptor Subtype EP3 in a Gβγ Subunit-Independent Manner"Biochem.Biophys.Res.Commun.. 290. 162-168 (2002)
Hatae, N.、Yamaoka, K.、Sugimoto 等人:“Gi 偶联前列腺素受体亚型 EP3 以 Gβγ 亚基独立方式增强受体介导的腺苷酸环化酶活性”Biochem.Biophys.Res.Commun. 290. 162-168 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Croy,B.A., et al.: "Prolonged gestation dose not extend survival of uterine natural killer lymphocytes in mice deleted in the receptor for prostaglandin F_<2α>."J.Reprod.Immunol.. 46. 125-129 (2000)
Croy, B.A. 等人:“在前列腺素 F_<2α> 受体缺失的小鼠中,延长妊娠不会延长子宫自然杀伤淋巴细胞的存活时间。”J.Reprod.Immunol.. 46. 125-129 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    Mechanisms for adhesion and leakage of pge_2-activated mast cells to and from extracellular matrix
    • 批准号:
      17590079
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2005
    • 负责人:
      ICHIKAWA Atsushi
    • 依托单位:
    A study for role of PGE2 on adhesion of mast cells to fibronectin
    • 批准号:
      15390024
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.79万
    • 财政年份:
      2003
    • 负责人:
      ICHIKAWA Atsushi
    • 依托单位:
    Biopharmaceutical Research on Prostaglandin Receptors
    • 批准号:
      12470496
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.5万
    • 财政年份:
      2000
    • 负责人:
      ICHIKAWA Atsushi
    • 依托单位:
    A study for drug-discovery based on physiological actions of prostanoid receptors
    • 批准号:
      10557222
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.64万
    • 财政年份:
      1998
    • 负责人:
      ICHIKAWA Atsushi
    • 依托单位:
    海外基金